Jan Kehler,Lar Kyhn Rasmussen,Morten Langgård,Mikkel Jessing,Paulo Jorge Vieira Vital,Karsten Juhl
申请号：
US16345157
公开号：
US20190282572A1
申请日:
2017.10.26
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides combination treatments comprising administration of compounds that are PDE1 enzyme inhibitors and other compounds useful in the treatment of neurodegenerative disorders such as for example Alzheimer's Disease, Parkinson's Disease or Huntington's Disease. Separate aspects of the invention are directed to the combined use of said compounds for the treatment of neurodegenerative and/or cognitive disorders. The present invention also provides pharmaceutical compositions comprising said PDE1 enzyme inhibitors together with other compounds useful in the treatment of neurodegenerative disorders.
